tradingkey.logo
tradingkey.logo
Search

Eupraxia Pharmaceuticals Inc

EPRX
Add to Watchlist
6.400USD
-0.150-2.29%
Close 07-31 16:00ETQuotes delayed by 15 min
416.54MMarket Cap
LossP/E TTM

EPRX Financials

See Eupraxia Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Eupraxia Pharmaceuticals Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.22/-0.19
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.97
-28.45%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
Financial Indicators
EPS
-17.74%-0.22
-54.62%-0.33
-3.28%-0.17
-44.33%-0.24
9.65%-0.19
---0.21
9.81%-0.17
60.42%-0.17
-16.86%-0.21
----
---0.18
---0.43
---0.18
----
----
----
----
----
----
----
----
----
----
Net Profit
-87.11%-12.65M
-122.55%-16.71M
-7.03%-6.36M
-45.51%-8.74M
-11.91%-6.76M
---7.51M
-25.88%-5.94M
35.94%-6.01M
-55.13%-6.04M
----
-17.34%-4.72M
-96.45%-9.38M
-33.69%-3.90M
----
-1.83%-4.02M
-7.89%-4.77M
58.36%-2.91M
-2691.02%-2.95M
-396.68%-3.95M
-838.60%-4.42M
-337.50%-7.00M
81.02%-105.68K
----
Debt to assets ratio
----
----
----
----
----
--0.00%
--0.00%
--18.23%
--25.98%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-132.96%-15.64M
-118.51%-15.69M
-12.42%-6.52M
-28.32%-7.91M
-6.75%-6.71M
---7.18M
11.47%-5.80M
-10.33%-6.16M
-80.54%-6.29M
----
-78.38%-6.55M
-17.68%-5.59M
-32.60%-3.48M
----
7.00%-3.67M
-19.26%-4.75M
33.53%-2.63M
-5451.19%-2.64M
-767.44%-3.95M
-847.75%-3.98M
-432.86%-3.95M
81.04%-47.62K
----
Net Profit
-87.11%-12.65M
-122.55%-16.71M
-7.03%-6.36M
-45.51%-8.74M
-11.91%-6.76M
---7.51M
-25.88%-5.94M
35.94%-6.01M
-55.13%-6.04M
----
-17.34%-4.72M
-96.45%-9.38M
-33.69%-3.90M
----
-1.83%-4.02M
-7.89%-4.77M
58.36%-2.91M
-2691.02%-2.95M
-396.68%-3.95M
-838.60%-4.42M
-337.50%-7.00M
81.02%-105.68K
----
Current assets
396.83%142.13M
147.12%85.10M
824.17%91.40M
-6.91%22.83M
-21.01%28.61M
--34.44M
--9.89M
--24.53M
--36.22M
----
----
----
----
----
-17.55%22.27M
-4.93%28.27M
-17.03%21.32M
2608.90%24.22M
6068.08%27.00M
--29.74M
--25.69M
--894.15K
--437.82K
Total current liabilities
234.66%7.36M
81.35%5.63M
60.62%3.81M
-77.43%2.62M
-88.13%2.20M
--3.10M
--2.37M
--11.60M
--18.53M
----
----
----
----
----
-27.38%1.63M
323.63%2.79M
-83.44%1.01M
-89.86%1.79M
-86.48%2.24M
--658.66K
--6.10M
--17.71M
--16.60M
Total assets
397.22%145.35M
146.55%86.15M
790.98%92.35M
-5.52%23.60M
-20.21%29.23M
--34.94M
--10.36M
--24.98M
--36.64M
----
----
----
----
----
-17.39%22.75M
-3.92%28.79M
-16.07%21.76M
2064.25%24.71M
3883.54%27.54M
--29.97M
--25.93M
--1.14M
--691.23K
Total liabilities
316.62%9.17M
83.80%5.70M
63.61%3.91M
-77.50%2.62M
-88.13%2.20M
--3.10M
--2.39M
--11.64M
--18.53M
----
----
----
----
----
-6.05%8.95M
34.90%10.45M
39.39%8.70M
-49.14%9.24M
-44.26%9.52M
--7.75M
--6.24M
--18.16M
--17.08M
Total equity
403.78%136.19M
152.67%80.45M
1008.61%88.44M
57.28%20.98M
49.30%27.03M
--31.84M
--7.98M
--13.34M
--18.11M
----
----
----
----
----
-23.38%13.80M
-17.46%18.34M
-33.67%13.06M
190.94%15.48M
209.88%18.01M
--22.22M
--19.68M
---17.02M
---16.39M
Net operating income
-69.03%-10.15M
-62.87%-9.73M
55.77%-4.51M
-7.82%-8.32M
1.92%-6.00M
-0.13%-5.97M
-71.41%-10.19M
-80.53%-7.71M
-34.01%-6.12M
---5.96M
-31.92%-5.94M
-46.33%-4.27M
-48.93%-4.57M
----
-128.69%-4.51M
15.26%-2.92M
11.22%-3.07M
-3236.77%-2.82M
---1.97M
---3.45M
-1019.75%-3.45M
----
----
Net investment
-47255.43%-80.05M
-341.76%-193.30K
-42.82%-60.38K
-1041.14%-166.22K
-2389.97%-169.04K
11.40%-43.76K
-340.27%-42.27K
379.37%17.66K
15.85%-6.79K
---49.38K
75.32%-9.60K
99.91%-6.32K
-50.79%-8.07K
----
86.67%-38.91K
-661543.71%-7.18M
99.87%-5.35K
---7.15M
---291.86K
---1.08K
-24865.32%-4.00M
----
----
Net financing
15852.39%68.58M
-95.30%1.49M
1706.03%73.90M
105.33%239.78K
-98.14%429.92K
532658.26%31.73M
-128.25%-4.60M
-198.01%-4.50M
11797.52%23.15M
--5.96K
45515.00%16.29M
-55.80%4.59M
645.93%194.61K
----
-111.31%-35.86K
37.90%10.39M
-100.11%-35.65K
9.26%-117.58K
--317.06K
--7.53M
4237.05%31.91M
----
----

FAQs

What are the current assets of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its current assets were 85.10M, with a year-on-year change of 147.12.

What are the total assets of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its total assets of Eupraxia Pharmaceuticals Inc were 86.15M, with a year-on-year change of 146.55.

What are the total liabilities of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Eupraxia Pharmaceuticals Inc were 5.70M, with a year-on-year change of 83.80.

What is the total equity of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its total equity of Eupraxia Pharmaceuticals Inc was 80.45M, with a year-on-year change of 152.67.

What is the net operating income of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Eupraxia Pharmaceuticals Inc was -36.84M, with a year-on-year change of -44.83.

What is the net investment of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its net investment of Eupraxia Pharmaceuticals Inc was -588.95K, with a year-on-year change of -683.60.

What is the net financing of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its net financing of Eupraxia Pharmaceuticals Inc was 76.06M, with a year-on-year change of 66.12.

What is the Earnings Per Share (EPS) of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.97, with a year-on-year change of -28.45.

What is the net income of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its net income was -38.58M, with a year-on-year change of -51.26.

What is the Return on Equity (ROE) of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -142.87, with a year-on-year change of 89.03.

What is the Return on Assets (ROA) of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -63.76, with a year-on-year change of 31.63.

What is the operating profit of Eupraxia Pharmaceuticals Inc?

According to Eupraxia Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -36.84M, with a year-on-year change of -44.83.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.